Paid Clinical Trials Great Falls

Discover 110 paid clinical trials in Great Falls, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 110

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Great Falls MT, Havre MT, Anaconda MT, Bozeman MTshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After SurgeryUsing Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Great Falls MT, Anaconda MT, Bozeman MT, Missoula MTshow 109 more

Code:

NCT05111574

Conditions

Anal Melanoma

Bladder Melanoma

Cervical Melanoma

Esophageal Melanoma

Gallbladder Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

MFOLFIRINOX Versus MFOLFOX with or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaMFOLFIRINOX Versus MFOLFOX with or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Recruiting

PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Great Falls MT, Butte MT, Anaconda MT, Bozeman MTshow 465 more

Code:

NCT05677490

Conditions

Advanced Esophageal Adenocarcinoma

Advanced Gastric Adenocarcinoma

Advanced Gastroesophageal Junction Adenocarcinoma

Clinical Stage III Esophageal Adenocarcinoma AJCC V8

Clinical Stage III Gastric Cancer AJCC V8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fluorouracil

Leucovorin Calcium

Oxaliplatin

Irinotecan

Nivolumab

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentTesting the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Great Falls MT, Bozeman MT, Missoula MT, Billings MTshow 42 more

Code:

NCT06589804

Conditions

Metastatic Head and Neck Squamous Cell Carcinoma

Metastatic Hypopharyngeal Squamous Cell Carcinoma

Metastatic Laryngeal Squamous Cell Carcinoma

Metastatic Oral Cavity Squamous Cell Carcinoma

Metastatic Oropharyngeal Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Cetuximab

Computed Tomography

Magnetic Resonance Imaging

Pembrolizumab

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialChemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Great Falls MT, Anaconda MT, Bozeman MT, Missoula MTshow 213 more

Code:

NCT06096844

Conditions

Advanced Lung Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IIIC Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 70+

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Computed Tomography

Magnetic Resonance Imaging

Nab-paclitaxel

Paclitaxel

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate CancerTesting the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Great Falls MT, Billings MT, Gresham OR, Vancouver WAshow 232 more

Code:

NCT04134260

Conditions

Prostate Adenocarcinoma

Stage I Prostate Cancer AJCC v8

Stage II Prostate Cancer AJCC v8

Stage IIA Prostate Cancer AJCC v8

Stage IIB Prostate Cancer AJCC v8

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Apalutamide

Hormone Therapy

Quality-of-Life Assessment

Questionnaire Administration

Radiation Therapy

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Great Falls MT, Helena MT, Anaconda MT, Bozeman MTshow 368 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) InfectionStudy of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

Recruiting

PHASE2

Sponsor:

Gilead Sciences

Location:

Great Falls MT, Missoula MT, Kalispell MT, Idaho Falls IDshow 26 more

Code:

NCT06784973

Conditions

RSV Infection

Eligibility Criteria

Sex: All

Age: 0 - 5

Healthy Volunteers: Not accepted

Interventions

Obeldesivir

Obeldesivir Placebo

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Great Falls MT, Bozeman MT, Missoula MT, Billings MTshow 85 more

Code:

NCT06116682

Conditions

Lung Non-Small Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder CancerTesting the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Great Falls MT, Butte MT, Anaconda MT, Bozeman MTshow 257 more

Code:

NCT04164082

Conditions

Bladder Flat Urothelial Carcinoma In Situ

Non-Muscle Invasive Bladder Urothelial Carcinoma

Stage 0a Bladder Cancer AJCC v8

Stage 0is Bladder Cancer AJCC v8

Stage I Bladder Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Computed Tomography

Cystoscopy

Gemcitabine Hydrochloride